Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Daiwa Capital Upgrades Pfizer to Outperform, Announces $51 Price Target

Daiwa Capital Upgrades Pfizer to Outperform, Announces $51 Price Target

Daiwa Capital analyst Narumi Nakagiri upgrades Pfizer (NYSE:PFE) from Neutral to Outperform and announces $51 price target.

February 7, 2023

1 minute read

Daiwa Capital analyst Narumi Nakagiri upgrades Pfizer (NYSE:PFE) from Neutral to Outperform and announces $51 price target.

Needham Maintains Buy on NVIDIA, Lowers Price Target to $170

September 2, 5:19 AM

Needham analyst Rajvindra Gill maintains NVIDIA (NASDAQ:NVDA) with a Buy and lowers the price target from $185 to $170.

May 6, 2:00 PM

Ratings for Commercial Vehicle Group (NASDAQ:CVGI) were provided by 4 analysts in the past three months, showcasing a…

April 18, 11:00 AM

In today’s rapidly changing and fiercely competitive business landscape, it is vital for investors and industry enthusiasts to…

October 30, 4:30 PM

Cognizant Tech Solns (NASDAQ:CTSH) has outperformed the market over the past 20 years by 5.74% on an annualized…